PLAP for Treating Bone Marrow Toxicity
Cancer therapies are generally toxic to the bone marrow. Using relevant animal
models, we have demonstrated that PLAP can greatly reduce therapy induced loss of
platelets as well as red and white blood cells primarily by protecting their blood
stem cell precursors.
The combined positive effects of PLAP on cachexia and bone marrow health will allow the
use of higher doses of cancer therapies with greater frequency resulting in longer
survival, or even a cure, of the cancer patient.